Israeli biotech Regentis Biomaterials files for $15M US IPO
2d illustrations and photos Israeli medical products developer Regentis Biomaterials has filed for a $15M US initial public offering. While Regentis didn’t specify the number or pricing of the securities to be offered, it said that it would be offering units, with each unit consisting of one share plus one warrant to buy one share. … Read more